The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 249-250 , August 2008

The elite athlete: Yes, with allergy we can

  • Sergio Bonini, MD

      Affiliations

    • Second University of Naples, Rome, Italy
    • Corresponding Author InformationReprint requests: Sergio Bonini, MD, Second University of Naples, Via Ugo de Carolis 59, Rome 00136, Italy.
    • ,
  • Timothy Craig, DO

      Affiliations

    • Pennsylvania State University, Allergy, Asthma and Immunology, Hershey, Pa

Received 23 May 2008 ,Revised 14 June 2008 ,Accepted 17 June 2008.

References 

  1. Weiler J, Weiler JM, Ryan EJ. Asthma in United States Olympic athletes who participated in the 1998 Olympic Winter Games. J Allergy Clin Immunol. 2000;106:267–271
  2. Katelaris CH, Carrozzi FM, Burke TV, Byth K. A springtime Olympics demands special consideration for allergic athletes. J Allergy Clin Immunol. 2000;106:260–266
  3. Lapucci G, Rasi G, Bonini S on behalf of the Aida. Study Group. Allergy and infectious diseases in athletes. J Allergy Clin Immunol. 2003;111:S142
  4. Pedersen BK, Rohde T, Zacho M. Immunity in athletes. J Sports Med Phys Fitness. 1996;36:236–245
  5. Konig D, Grathwohl D, Weinstock C, Northoff H, Berg A. Upper respiratory tract infections in athletes: influence of lifestyle, type of sport, training effort and immunostimulant intake. Exerc Immunol Rev. 2000;6:102–120
  6. Anderson SD, Kippelen P. Airway injury as a mechanism for exercise-induced broncoconstriction in elite athletes. J Allergy Clin Immunol. 2008;122:225–235
  7. WADA. The World Anti-Doping Agency: the 2008 Prohibited List: International Standard (effective Jan. 1, 2008). Available at: http://www.wada-ama.org. Accessed July 1, 2008.
  8. Nelson HS. Is there a problem with inhaled long-acting β2 adrenergic agonists?. J Allergy Clin Immunol. 2006;117:3–16
  9. Anderson SD, Fitch K, Perry CP, Sue-Chu M, Crapo R, McKenzie D, et al. Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics. J Allergy Clin Immunol. 2003;111:45–50
  10. Martinez FD. Safety of long-acting beta-agonists: an urgent need to clear the air. N Engl J Med. 2005;353:2637–2639
  11. Fitch KD. beta2-Agonists at the Olympic Games. Clin Rev Allergy Immunol. 2006;31:259–268
  12. Weinberger M. Long-acting β-agonists and exercise. J Allergy Clin Immunol. 2008;122:251–253
  13. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol. 2008;122:238–246

 Supported by the Italian Ministry of Health, Commission for Vigilance and Control of Doping (S.B.).

 Disclosure of potential conflict of interest: S. Bonini has a research appointment at the Institute of Neurobiology and Molecular Medicine, Italian National Research Council; is a member of the Research and Development Commission of the Italian Drug Agency; and has received research grants, consultancies, and honoraria from participation in speakers' bureaus for Alcon, Allergopharma, Allergy Therapeutics, ALK, Almirall, Aventis, AstraZeneca, Bioallergy, Bioxell, GlaxoSmithKline, Lofarma, Merch Sharp and Dohme, Novartis, Pfizer, Sanofi-Synthelabo, Schering-Plough, Stallaergens, UCB, and Zambon. T. Craig has declared that he has no conflict of interest.

PII: S0091-6749(08)01146-9

doi: 10.1016/j.jaci.2008.06.020

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 249-250 , August 2008

Article Tools

* Image Usage & Resolution